Correlation Between Connect Biopharma and Eton Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Eton Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Eton Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and Eton Pharmaceuticals, you can compare the effects of market volatilities on Connect Biopharma and Eton Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Eton Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Eton Pharmaceuticals.

Diversification Opportunities for Connect Biopharma and Eton Pharmaceuticals

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between Connect and Eton is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Eton Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eton Pharmaceuticals and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Eton Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eton Pharmaceuticals has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Eton Pharmaceuticals go up and down completely randomly.

Pair Corralation between Connect Biopharma and Eton Pharmaceuticals

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to under-perform the Eton Pharmaceuticals. In addition to that, Connect Biopharma is 1.04 times more volatile than Eton Pharmaceuticals. It trades about -0.17 of its total potential returns per unit of risk. Eton Pharmaceuticals is currently generating about 0.29 per unit of volatility. If you would invest  813.00  in Eton Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of  262.00  from holding Eton Pharmaceuticals or generate 32.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Connect Biopharma Holdings  vs.  Eton Pharmaceuticals

 Performance 
       Timeline  
Connect Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Connect Biopharma Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Connect Biopharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Eton Pharmaceuticals 

Risk-Adjusted Performance

28 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eton Pharmaceuticals are ranked lower than 28 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Eton Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Connect Biopharma and Eton Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Connect Biopharma and Eton Pharmaceuticals

The main advantage of trading using opposite Connect Biopharma and Eton Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Eton Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will offset losses from the drop in Eton Pharmaceuticals' long position.
The idea behind Connect Biopharma Holdings and Eton Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges